Alvogen Recalls Clindamycin Injection Vials Due to Sterility Concerns
Alvogen, Inc. is recalling specific lots of Clindamycin Injection USP due to a lack of assurance of sterility. The recall covers 71,825 vials distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or death from infection.
Plain-English summary
Alvogen, Inc. is recalling 71,825 6 mL single-dose vials of Clindamycin Injection USP (900 mg/6 mL). The recall is being conducted because of a lack of assurance of sterility in the product. The affected product is manufactured for Alvogen, Inc., located in Pine Brook, NJ, and is available by prescription only.
The recall includes lots 68-105-EV (expiration 07/31/18), 68-106-EV (expiration 07/31/18), and 73-157-EV (expiration 12/31/18). The product was distributed nationwide. The NDC number for the recalled product is 47781-464-69.
Healthcare providers and patients should check their inventory and medication records for these specific lot numbers. If you have this product, do not use it and contact your healthcare provider or pharmacist for guidance on replacement or disposal.
The recalled product
- Product
- Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-464-69
- Manufacturer
- Alvogen, Inc
- Category
- Drug — Injectable Antibiotic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: 68-105-EV
- Exp. 07/31/18
- 68-106-EV
- Exp. 07/31/18
- and 73-157-EV
- Exp. 12/31/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Alvogen, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Alvogen, Inc
See all →- ModerateCarotid anesthesia kits recalled over recalled B. Braun administration sets inside
FDA (Drugs) · 2026-01-21
- SevereFentanyl Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2025-02-26
- ModeratePrescription Levothyroxine Sodium Tablets Recalled Due to Sub-Potency
FDA (Drugs) · 2023-03-08
- SevereAlvogen Buprenorphine and Naloxone Sublingual Film recalled for subpotent active ingredients
FDA (Drugs) · 2021-07-14
- ModerateAlvogen Recalls Macrobid Nitrofurantoin Due to Failed Dissolution Specifications
FDA (Drugs) · 2019-08-21
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29